Data / Drug companies / Lisinopril and hydrochlorothiazide tablets
Lisinopril and hydrochlorothiazide tablets: 12 companies and 38 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Lisinopril and hydrochlorothiazide tablets is listed in the FDA National Drug Code Directory by 12 companies, with 38 products in commercial distribution. 38 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on November 6, 2025.
The request: Get every company that lists lisinopril and hydrochlorothiazide tablets in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 38
- Generic (ANDA) products
- 38 (100.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Lisinopril and Hydrochlorothiazide
- openFDA record search
- api.fda.gov
Companies that list lisinopril and hydrochlorothiazide tablets
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 7 | tablet | Generic drugs (ANDA) | December 26, 2019 |
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | December 26, 2019 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | tablet | Generic drugs (ANDA) | May 1, 2019 |
| NuCare Pharmaceuticals,Inc. | 4 | tablet | Generic drugs (ANDA) | December 26, 2019 |
| Cipla USA Inc. | 3 | tablet | Generic drugs (ANDA) | December 26, 2019 |
| Exelan Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | May 1, 2019 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | October 1, 2022 |
| Solco Healthcare US, LLC | 3 | tablet | Generic drugs (ANDA) | March 12, 2015 |
| Remedyrepack Inc. | 2 | tablet | Generic drugs (ANDA) | November 6, 2025 |
| St. Mary's Medical Park Pharmacy | 2 | tablet | Generic drugs (ANDA) | June 29, 2023 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | March 12, 2015 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | March 12, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 38 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 38 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin Converting Enzyme Inhibitor | 38 |
| Thiazide Diuretic | 38 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.